Clinical Trial Update: Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage [NA]

View source ↗

Summary

A clinical trial update notes a planned immune-targeted combination with chemotherapy for adult acute leukemia with ambiguous lineage (ALL/MPAL) that is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Mixed Phenotype Acute Leukemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Adult ALL, MPAL | NA | Status: NOT_YET_RECRUITING